Literature DB >> 16953836

Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population.

Naoki Tanaka1, Eiji Tanaka, Yo Sheena, Michiharu Komatsu, Wataru Okiyama, Noriko Misawa, Hidetomo Muto, Takeji Umemura, Tetsuya Ichijo, Akihiro Matsumoto, Kaname Yoshizawa, Akira Horiuchi, Kendo Kiyosawa.   

Abstract

BACKGROUND/AIMS: As detecting mild steatosis is difficult by abdominal ultrasonography (US), nonalcoholic steatohepatitis (NASH) with mild steatosis may sometimes be confused with cryptogenic chronic hepatitis. We aimed to test this possibility and to isolate factors that may indicate NASH.
METHODS: First, 53 Japanese patients diagnosed as having cryptogenic chronic hepatitis by laboratory examination and US were enrolled. These patients were histologically divided into NASH and non-NASH groups, and their clinical features were compared. Second, the diagnostic accuracy of predictors of NASH was examined prospectively.
RESULTS: Fifteen patients (28%) were histologically diagnosed as having NASH with mild steatosis. Multivariable analysis revealed that body mass index (BMI) and serum ferritin level were independent predictors of NASH. The best cutoff values to detect NASH were assessed by using receiver-operating characteristic curves: BMI>25.2 kg/m(2) and serum ferritin level >142 ng/ml. When both markers were concomitantly negative, the negative predictive value to detect NASH was 100%.
CONCLUSIONS: In cases of mild steatosis, US is not a perfect tool for the accurate diagnosis of NASH. BMI and serum ferritin level are useful discriminators of NASH from cryptogenic chronic hepatitis, and might be helpful markers for diagnosing NASH more accurately in Japanese patients.

Entities:  

Mesh:

Year:  2006        PMID: 16953836     DOI: 10.1111/j.1478-3231.2006.01338.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  11 in total

1.  Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease.

Authors:  Tomoko Hatta; Yasunari Fujinaga; Masumi Kadoya; Hitoshi Ueda; Hiroaki Murayama; Masahiro Kurozumi; Kazuhiko Ueda; Michiharu Komatsu; Tadanobu Nagaya; Satoru Joshita; Ryo Kodama; Eiji Tanaka; Tsuyoshi Uehara; Kenji Sano; Naoki Tanaka
Journal:  J Gastroenterol       Date:  2010-07-13       Impact factor: 7.527

2.  Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.

Authors:  Zheng Chen; Cheng-Kun Han; Ling-Ling Pan; Hui-Jie Zhang; Zhi-Min Ma; Zhu-Feng Huang; Shi Chen; Xiong-Jie Zhuang; Zhi-Bin Li; Xiao-Ying Li; Xue-Jun Li; Shu-Yu Yang
Journal:  Dig Dis Sci       Date:  2014-05-27       Impact factor: 3.199

3.  Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahide Yokoyama; Gengo Kaneko; Naoto Horigome; Takahiro Yamaura; Tadanobu Nagaya; Michiharu Komatsu; Kenji Sano; Shin-Ichi Miyagawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

4.  Gender-related variations in iron metabolism and liver diseases.

Authors:  Duygu D Harrison-Findik
Journal:  World J Hepatol       Date:  2010-08-27

5.  Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.

Authors:  Yuta Aida; Hiroshi Abe; Yoichi Tomita; Tomohisa Nagano; Nobuyoshi Seki; Tomonori Sugita; Munenori Itagaki; Haruya Ishiguro; Satoshi Sutoh; Yoshio Aizawa
Journal:  Int J Clin Exp Med       Date:  2014-11-15

6.  Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.

Authors:  Tadanobu Nagaya; Naoki Tanaka; Michiharu Komatsu; Tetsuya Ichijo; Kenji Sano; Akira Horiuchi; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Kendo Kiyosawa; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2008-07-12

7.  Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Takahide Yokoyama; Shinji Okaniwa; Tadanobu Nagaya; Kaname Yoshizawa; Kendo Kiyosawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2009-04-08       Impact factor: 7.527

8.  Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse model.

Authors:  Yufeng Li; Eiko Sugiyama; Shin Yokoyama; Lingling Jiang; Naoki Tanaka; Toshifumi Aoyama
Journal:  Lipids       Date:  2008-03-12       Impact factor: 1.880

9.  Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease.

Authors:  Kyoung Ah Kwon; Peter Chun; Jae Hong Park
Journal:  Korean J Pediatr       Date:  2016-09-21

10.  Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.

Authors:  Ming-Shyan Lin; Huang-Shen Lin; Chang-Ming Chung; Yu-Sheng Lin; Mei-Yen Chen; Po-Han Chen; Jing-Hong Hu; Wen-Nan Chou; Jui-Chu Huang; Tung-Jung Huang
Journal:  BMJ Open       Date:  2015-09-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.